SHP Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.83M Sell
2,353
-2
-0.1% -$2.36K 0.19% 43
2026
Q2
$2.83M Buy
2,355
+62
+3% +$63.3K 0.19% 43
2026
Q1
$2.11M Sell
2,293
-215
-9% -$218K 0.16% 43
2025
Q4
$2.7M Buy
+2,508
New +$2.4M 0.21% 36

Other funds holding LLY

SHP Wealth Management's LLY Position: Q3 2026 in Review

SHP Wealth Management reduced its Eli Lilly (LLY) stake by 0.08% in Q3 2026, selling an estimated $2.36K and leaving 2,353 shares worth $2.83M. The position accounts for 0.19% of the portfolio, ranked #43.

SHP Wealth Management first reported a position in LLY in Q4 2025 and has held it in 4 quarters since. The position peaked at $2.83M in Q2 2026. 4,631 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • SHP Wealth Management held 2,353 shares of Eli Lilly worth $2.83M as of Q3 2026.
  • SHP Wealth Management sold 2 Eli Lilly shares in Q3 2026, an estimated $2.36K.
  • Eli Lilly made up 0.19% of SHP Wealth Management's portfolio in Q3 2026, its #43 holding.
  • SHP Wealth Management first reported a position in Eli Lilly in Q4 2025 and has held it in 4 quarters since.
  • SHP Wealth Management's Eli Lilly position peaked at $2.83M in Q2 2026.
  • 4,631 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on SHP Wealth Management's 13F filing for Q3 2026, filed 19 Nov 2026.